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Asthma and allergy are complex diseases in
which numerous genetic and environmental
factors play a role in the etiology. Air pollu-
tants, including vehicle-related pollutants
such as particles and nitrogen oxides (NOx),
are known to induce airway inflammation
and increase airway responsiveness (Gilmour
et al. 2006; Grievink et al. 2000). It is plausi-
ble that genetic variants in the genes control-
ling the inflammatory and antioxidative
systems may determine whether exposure to
air pollutants will promote the development
of allergic diseases. Identification of such
gene–environment interactions may hold the
key to understanding the great variability
among individuals in responses to various
environmental factors, among them environ-
mental tobacco smoke, ozone, and diesel
exhaust particles (London 2007).
The inﬂammatory response after exposure
to air pollutants is maintained by the activa-
tion of proinflammatory molecules and may
also induce lung damage due to generation of
reactive oxygen species (MacNee 2001).
Further, diesel exhaust particles may induce
IgE responses directly by acting on B-cells and
enhancing the production of cytokines that
favor the development of an allergy-prone
immune response (Sydbom et al. 2001).
Members of the glutathione S-transferase
(GST) supergene family have been a particular
focus of studies of gene–environment inter-
actions, because they constitute an intracellular
protective system against electrophiles and the
formation of hazardous reactive oxygen species
(Hayes and Strange 1995; McCunney 2005;
Strange et al. 2001). Recent studies support
the presence of gene–environment interaction,
or effect modiﬁcation, between exposure to air
pollutants and glutathione S-transferase P1
(GSTP1) variants, especially the isoleucine
(Ile)/valine (Val) polymorphism at amino acid
position 105 with respect to childhood asthma
and nasal allergic responses (Gilliland et al.
2004; Lee et al. 2004). Although GSTP1 is the
GST enzyme most expressed in the lung (Fryer
et al. 1986), deficiency of two other GST
genes, GSTM1 and GSTT1, has also been
shown to inﬂuence the effect of passive smok-
ing on the risk of childhood asthma and
wheezing (Gilliland et al. 2002b; Kabesch
et al. 2004). Other systems have also been
implicated in interactions with air pollution.
Interaction between exposure to ozone and
tumor necrosis factor (TNF superfamily, mem-
ber 2) polymorphisms, especially TNF
G-308A, has been observed with regard to
lung function and childhood wheezing (Li
et al. 2006; Yang et al. 2005). Effect modiﬁca-
tion of exposure to passive smoking on the fre-
quency of school absences due to respiratory
illness has also been reported, supporting a role
of TNF as a key player in relation to air pollu-
tants (Wenten et al. 2005; Wu et al. 2007).
Recently, the effect of passive smoking on
asthma phenotypes in children was also
reported to be modiﬁed by polymorphisms in
the β2-adrenergic receptor (ADRB2) gene
(Zhang et al. 2007), which supports previously
observations in adults (Wang et al. 2001).
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BACKGROUND: Air pollutants may induce airway inﬂammation and sensitization due to generation
of reactive oxygen species. The genetic background to these mechanisms could be important effect
modiﬁers.
OBJECTIVE: Our goal was to assess interactions between exposure to air pollution and single
nucleotide polymorphisms (SNPs) in the β2-adrenergic receptor (ADRB2), glutathione S-transferase
P1 (GSTP1), and tumor necrosis factor (TNF) genes for development of childhood allergic disease.
METHODS: In a birth cohort originally of 4,089 children, we assessed air pollution from local trafﬁc
using nitrogen oxides (trafﬁc NOx) as an indicator based on emission databases and dispersion model-
ing and estimated individual exposure through geocoding of home addresses. We measured peak expi-
ratory flow rates and specific IgE for inhalant and food allergens at 4 years of age, and selected
children with asthma symptoms up to 4 years of age (n = 542) and controls (n = 542) for genotyping.
RESULTS: Interaction effects on allergic sensitization were indicated between several GSTP1 SNPs
and traffic NOx exposure during the first year of life (pnominal < 0.001–0.06). Children with
Ile105Val/Val105Val genotypes were at increased risk of sensitization to any allergen when exposed
to elevated levels of trafﬁc NOx (for a difference between the 5th and 95th percentile of exposure:
odds ratio = 2.4; 95% conﬁdence interval, 1.0–5.3). In children with TNF-308 GA/AA genotypes,
the GSTP1–NOx interaction effect was even more pronounced. We observed no conclusive inter-
action effects for ADRB2.
CONCLUSION: The effect of air pollution from trafﬁc on childhood allergy appears to be modiﬁed
by GSTP1 and TNF variants, supporting a role of genes controlling the antioxidative system and
inﬂammatory response in allergy.
KEY WORDS: ADRB2, air pollution, allergy, asthma, genetics, GSTP1, interaction, nitrogen oxides,
polymorphism, TNF. Environ Health Perspect 116:1077–1084 (2008). doi:10.1289/ehp.11117
available via http://dx.doi.org/ [Online 25 March 2008]We have previously reported significant
effects of exposure to traffic-related air
pollutants during the ﬁrst year life on respira-
tory symptoms, lung function, and sensitization
up to 4 years of age in the Swedish birth cohort
study BAMSE (the Children, Allergy, Milieu,
Stockholm, Epidemiological Survey) (Nordling
et al. 2008). The objective of the present study
was to identify interactions between certain
genetic variants and individual long-term expo-
sure to air pollutants from trafﬁc (evaluated as
trafﬁc-speciﬁc NOx) on the development of res-
piratory symptoms and allergic sensitization in
children. We evaluated genes that have previ-
ously been identiﬁed as target genes for allergic
diseases and with a potential for interaction
with air pollutants in order to select suitable
candidates from among genes that are involved
in the inﬂammatory response and antioxidative
pathway, or as airway receptors (Devalia et al.
1993; Forsberg et al. 2001; Holgate 1999;
MacNee 2001; Wang et al. 2001). Thus, based
on the considerations and prior data presented
above, we selected the TNF, ADRB2, and
GSTP1 genes for analyses.
Materials and Methods
Study design. Between 1994 and 1996, 4,089
newborn infants were recruited in the BAMSE
study, and questionnaire data on parental
allergic diseases and residential characteristics
were obtained (Melen et al. 2004b; Nordling
et al. 2008). The catchment area included cen-
tral and northwestern parts of Stockholm, that
is, the municipalities Järfälla, Solna, and
Sundbyberg and two inner-city districts,
Vasastan and Norrmalm. Thus, both urban
and suburban districts were represented. When
their children were 1, 2, and 4 years of age, par-
ents answered questionnaires on the children’s
symptoms related to asthma and other allergic
diseases. At approximately 4 years of age, 2,965
of the children participated in a clinical testing.
At this visit, peak expiratory ﬂow (PEF) tests
were performed using the normal-range Ferraris
peak flow meters (Ferraris Medical Ltd.,
Hertford, UK) (Hallberg et al. 2006). Each
child recorded several PEF measurements, and
we used the best PEF value for analysis.
Seventeen children refused to do PEF measure-
ments, and we excluded data from 349 children
because of inability to perform acceptable tests
(as judged by the test leader or inability to pro-
duce two reproducible PEF values within
15%), leaving 2,599 children with acceptable
PEF-readings (88%). Blood samples were also
drawn from 2,614 children.
The study design for the genetics part of
BAMSE has been presented elsewhere in detail
(Melen et al. 2004a, 2004b, 2005). For the
genetic analyses, 2,298 blood samples were
available after exclusion of 69 samples because
of too little blood, 81 samples because of lack
of questionnaire data, and 166 samples
because parental consent to genetic analysis of
the sample was not obtained (Figure 1). From
these 2,298 samples, for cost-efﬁciency reasons
we selected a subsample for genetic analyses,
using a case–cohort design. First, a randomly
sampled subcohort of 709 children provided
542 nonwheezers as an unbiased control sam-
ple for analyses using this phenotype, as well
as 167 wheezers. In addition, we selected all
remaining wheezers among the 2,298, provid-
ing a further 375 wheezers, totaling 542 cases
with the wheeze phenotype. We extracted
DNA from all of the 1,084 selected samples.
Extraction failed for 29 samples, leaving 1,055
samples for genotyping of TNF, ADRB2, and
GSTP1 single nucleotide polymorphisms
(SNPs), but we subsequently excluded 40 con-
trols and 33 wheezers because of > 50% miss-
ing data from genotype failures, indicating
poor DNA quality. Thus, we included 982
children (497 wheezing cases, 485 controls, of
whom 150 wheezers and 485 controls were
from the subcohort) in the analyses.
The subcohort mirrors the full BAMSE
cohort well in terms of sociodemographic fac-
tors, wheeze, and sensitization prevalence
(Melen et al. 2004a). The subcohort obtained
using the case–cohort design has the advan-
tage of providing effect estimates for other
outcomes than wheezing (e.g., sensitization
and PEF) in a representative group of children
that are guaranteed to be unbiased by the
wheezing phenotype case–control selection.
On the other hand, the sample size (n = 635)
is smaller than the full genetics study sample
(n = 982), and other phenotypes may be
enriched among the wheezers, so if bias is not
suspected to be an issue, analysis using the full
sample size may instead be advantageous.
The study was approved by the ethical
committee at Karolinska Institutet, and
parental consent to genetic analyses was
obtained for all participating children.
Deﬁnitions of study phenotypes. We subdi-
vided children with history of wheezing into
three groups according to reported episodes
during the early (3 months to 2 years) and
recent (last 12 months at 4 years) age periods
(Figure 1), using the following criteria (Melen
et al. 2004b): a) transient wheezing: three or
more episodes of wheezing between 3 months
Melén et al.
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Figure 1. The BAMSE study design: selection of subjects for genotyping and exclusion of subjects follow-
ing the genotyping procedure.
4,089 children were included in the
original birth cohort
Blood samples were drawn from 2,614
children at 4 years
69 samples had too little blood, 81
samples had lack of questionnaire data,
and for 166 samples, parental consent
to genetic analysis was not obtained
2,298 samples with adequate blood
volume and parental consent to genetic
analysis
Case–cohort sampling for genetics
All additional wheezers (n = 375) selected from
remaining blood cohort (2,298 – 709)
Random selection of subcohort (n = 709) from
blood sample cohort
167 wheezers, 542 nonwheezing controls
Extraction failed for 29 samples
Genotyping sample of wheezing cases at 4 years (n = 542) and nonwheezing controls (n = 542)
DNA extraction
1,055 samples were genotyped for TNF,
ADRB2, and GSTP1 SNPs
40 controls and 33 wheezers excluded
due to > 50% missing data from
genotype failures
982 samples were finally included in the statistical analysis of three separate outcomes:
A. 497 wheezing cases
•  155 transient wheeze
•  211 persistent wheeze
•  131 late onset wheeze
      (136 also had current asthma)
485 nonwheezing controls
B. 266 sensitized children (cases)
362 nonsensitized, nonwheeze (controls)
C. 860 acceptable PEF values
(continuous variable)and 2 years of age, but no episode in the pre-
ceding 12 months at 4 years; b) persistent
wheezing: one or more episodes of wheezing
between 3 months and 2 years of age and one
or more episodes in the preceding 12 months at
4 years; and c) late-onset wheezing: no episode
of wheezing between 3 months and 2 years of
age, but one or more episodes in the preceding
12 months at 4 years. We defined current
asthma as reported physician-diagnosed asthma
up to 4 years of age and one or more episodes
of wheezing in the preceding 12 months at
4 years (nonwheezing children without asthma
diagnosis at 4 years served as controls).
We measured sensitization to either
inhalant or food allergens [serum IgE anti-
bodies ≥ 0.35 kilounits of antibody per liter
(kUA/L)] with Phadiatop (Phadia AB,
Uppsala, Sweden): a mixture of cat, dog, horse,
birch, timothy, mugwort, Dermatophagoides
pteronyssinus, and Cladosporium allergens and
fx5 (Phadia AB): a mixture of milk, egg white,
soy bean, peanut, fish, and wheat allergens.
Twenty-nine percent of the wheezing cases
were sensitized, versus 25% of the controls [see
Supplemental Material, Table 1 (http://www.
ehponline.org/members/2008/11117/suppl.
pdf)], in total providing 266 sensitized cases.
To investigate whether the degree of sensitiza-
tion might inﬂuence the results, we also used a
higher cutoff for serum IgE antibodies (≥ 3.5
kUA/L) in some analyses. Of the 982 children
with genotype information, 860 performed
acceptable PEF tests (88%), and we used PEF
as a continuous variable. In the subcohort of
635 children, 175 were sensitized to inhalant
or food allergens (28%), and 557 (88%) had
acceptable PEF measurements.
Air pollution assessment. We based the
assessment of exposure to locally emitted air
pollution on a methodology developed to ret-
rospectively estimate long-term source-spe-
cific exposure to air pollution in the study
area, described in detail elsewhere (Nordling
et al. 2008; Rosenlund et al. 2006). It entails
geocoding of an individual’s address informa-
tion and uses an emission inventory together
with dispersion models to map outdoor levels
of selected pollutants from selected emission
sources over time at the relevant geographical
locations. Thus, we used this methodology to
assess the children’s individual exposure to
trafﬁc-related NOx during their life but focus-
ing on the ﬁrst year of life.
We retrieved residential address informa-
tion from the questionnaires at 2 months and
1 year of age and transformed this into
geographical coordinates (geocoded) using
standard geographical information systems
computer software (MapInfo; Pitney Bowes
MapInfo, Troy, NY, USA), in combination
with an address database. Emission databases
describing trafﬁc-generated NOx (trafﬁc NOx)
within the county were available for the years
1990 and 2000. We assessed the geographical
distribution of air pollution in three different
grid resolutions, applied to regional/country-
side (500 × 500 m), urban (100 × 100 m),
and inner-city (25 × 25 m) areas. In addition,
because the air pollution levels in the city also
depend on very local traffic conditions, we
added a street canyon contribution for
addresses in the most polluted street segments
in the city center (3% of the addresses). We
estimated the dispersion of pollutants from the
sources with a dilution model based on the
average annual distribution of wind speed,
direction, and precipitation.
We calculated residential outdoor levels of
trafﬁc NOx for each month at each address dur-
ing each child’s ﬁrst year of life (in the period
1994–1997) from the 1990 and 2000 values
for that address, by interpolation between these
two values assuming a linear change in air pol-
lution levels between these years in each point.
We veriﬁed close to linear trends from graphs
of annual means for the years concerned.
In the previously reported main effect
results for air pollution in the BAMSE cohort,
Nordling et al. (2008) noted a high correla-
tion between exposure to trafﬁc NOx and traf-
ﬁc particulate matter ≤ 10 µm in aerodynamic
diameter (PM10) (estimated by similar
methodology; r = 0.94), and we chose here to
present only NOx analyses as a proxy for air
pollution exposure from traffic. Validation
analyses showed good agreement (r = 0.74)
between calculated trafﬁc-related NO2 levels,
based on our assessed annual trafﬁc NOx lev-
els, and measured 1-month outdoor levels of
ambient NO2 (Nordling et al. 2008).
SNPs and genotyping. We extracted DNA
from peripheral blood leukocytes using a stan-
dard nonenzymatic method or the Puregene kit
(Gentra Systems, Minneapolis, MN, USA). We
selected a number of registered SNPs [prefer-
ably with proven or suggested functional effects
based on the existing literature or according to
the National Center for Biotechnology
Information (NCBI) database] in each of the
TNF, ADRB2, and GSTP1 genes from the
NCBI database and validated in 35 unrelated
Centre d’Etude du Polymorphisme Humain
(CEPH) individuals. Of nine selected SNPs in
the ADRB2 gene (GenBank accession no.
M15169; http://www.ncbi.nlm.nih.gov/entrez/
viewer.fcgi?db=nuccore&id=178201), two were
monomorphic or had very low minor allele
frequency (rs1800888 and rs3729943), three
had a success rate below 85%, the call rate
cutoff used in the 35-sample validation
step [rs1042711, rs1042713/Arg16Gly, and
rs1042719 (Arg, arginine; Gly, glycine)], and
one was out of Hardy-Weinberg equilibrium
(HWE) (p < 0.01; rs1042721), leaving three
SNPs for complete analysis [rs1042714/
Glu27Gln, rs1042717, and rs1042718 (Glu,
glutamate; Gln, glutamine)]. Of seven potential
SNPs in the TNF gene (GenBank accession no.
M16441; http://www.ncbi.nlm.nih.gov/entrez/
viewer.fcgi?db=nuccore&id=339739), one was
monomorphic (rs3093665), and one had a suc-
cess rate below 85% (rs1800630/–863), leaving
five SNPs for complete analysis (rs1799964/
–1031, rs1799724/–857, rs1800629/–308,
rs1800610, and rs3093664). Out of seven
selected GSTP1 (GenBank accession no.
M24485; http://www.ncbi.nlm.nih.gov/entrez/
viewer.fcgi?db=nuccore&id=341173) SNPs,
one we excluded because of success rate below
85% (rs1871041) and included the remaining
six SNPs in the study [rs762803, rs947894/
Ile105Val, rs749174, rs1799811/Ala114Val,
rs1871042, and rs4891 (Ala, alanine)].
We then analyzed the included SNPs in
all wheezing cases and controls (n = 982). We
designed primers for multiplexing PCR and
extension reactions by the SpectroDesigner
software (Sequenom, San Diego, CA, USA)
and performed PCR and extension reactions
according to standard protocols (detailed
information is available from the authors on
request). We performed the SNP analysis by
matrix-assisted laser desorption/ionization–
time of ﬂight (MALDI-TOF) mass spectrom-
etry (Sequenom), which has an automatic
quality control program that checks all geno-
types with regard to consistency of genotypes,
peak intensity, signal-to-noise ratio, and the
like. In addition to using this program, we
also manually double-checked all genotypes as
an extra quality control step.
All SNPs included for analyses (Table 1)
were in HWE (p > 0.01) and had a geno-
typing success rate of 93–99%.
Statistical analyses. We evaluated devia-
tions of observed genotype frequencies from
HWE by the chi-square test. To check the
haplotype inheritance of the markers we esti-
mated the correlation (r2) and linkage dise-
quilibrium (LD) coefficient (D´) using
Haploview 3.2 (Barrett et al. 2005). We
estimated haplotype frequencies in cases and
controls combined using the expectation
maximization (EM) algorithm. As an initial
step, we screened main genetic effects by
allelic association tests because this provides
maximum power for testing in most cases
even if the true genetic model is not log-addi-
tive. We obtained p-values for differences in
allele (and haplotype) frequencies between
cases and controls using the chi-square test
and used a linear regression model to test for
associations with mean PEF values. For the
primary interaction test analyses, we used
model-free (unconstrained) genotype coding
with indicator (dummy) variables for het-
erozygote and rare homozygote genotypes to
investigate the pattern of effects across differ-
ent genotypes, except for SNPs where the rare
homozygotes were too few, in which case we
used a dominant genetic model. We then used
Genes and air pollution in children
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for PEF) to test for gene–environment inter-
actions between genotypes and exposure to traf-
ﬁc NOx by adding an interaction term between
the genotype and exposure of interest. We per-
formed a likelihood-ratio test between the
models with and without interaction terms to
test for genotype–exposure interaction. Thus,
the obtained p-value indicates a departure from
a multiplicative interaction model on the odds
ratio (OR) scale and indicates whether the
effect of a certain exposure is significantly
altered by presence of a genotype (Table 2).
For power reasons, we used a dominant coding
model to assess the genotype-speciﬁc OR for
wheezing or sensitization (linear regression for
PEF) related to a difference between the 5th
and 95th percentile of traffic NOx exposure
(analyzed as a continuous variable) during the
ﬁrst year of life (Tables 3, 4). Thus, we have
used different genetic models in the different
tables, which precludes direct comparison
between the effect measures. In the regression
model for wheezing and sensitization as out-
comes we adjusted for a number of potential
confounders: municipality (four categories),
socioeconomic status (six categories based the
parents’ occupation), heredity for allergic dis-
eases in three categories (none, one, or both
parents), maternal smoking during pregnancy
and/or in infancy (yes/no), construction year of
the residence (in three categories), dampness or
mold in the home at birth (yes/no), and sex of
Melén et al.
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Table 1. Association of asthma, wheezing, sensitization, and mean PEF values in 4-year-old children from a birth cohort in Stockholm for SNPs in the ADRB2, TNF,
and GSTP1 genes.
Allelic associations (p-valuea)
SNP Localization and MAF Asthma  Transient wheezing Late-onset wheezing  Persistent wheezing Sensitizationb PEFc
Gene symbol (major/minor allele) coding change (n = 982) (n = 136 cases) (n = 155 cases) (n = 131 cases) (n = 211 cases) (n = 266 cases) (n = 860)
ADRB2 rs1042714 (C/G) Exon 1, Glu27Gln  0.41 0.68 0.54 0.94 0.53 0.09 0.92
rs1042717 (G/A) Exon 1 0.19 0.41 0.11 0.32 0.18 0.80 0.92
rs1042718 (C/A) Exon 1 0.15 0.49 0.15 0.33 0.24 0.63 0.76
TNF rs1799964 (T/C) –1031 0.21 0.78 0.33 0.41 0.51 0.40 0.58
rs1799724 (C/T) –857 0.09 0.67 0.009d 0.24 0.91 0.95 0.78
rs1800629 (G/A) –308 0.16 0.03d 0.94 0.51 0.03d <0.005e 0.26
rs1800610 (C/T) Intron 1 0.09 0.96 0.03d 0.26 0.87 0.99 0.87
rs3093664 (A/G) Intron 3 0.08 0.47 0.32 0.75 0.93 0.75 0.87
GSTP1 rs762803 (C/A) Intron 4 0.41 0.26 0.16 0.39 0.26 0.36 0.81
rs1695 (A/G)
(rs947894) Exon 5, Ile105Val 0.33 0.97 0.57 0.38 0.90 0.93 0.48
rs749174 (C/T) Intron 5 0.34 0.36 0.55 0.94 0.30 0.83 0.70
rs1138272 (C/T)
(rs1799811) Exon 6, Ala114Val 0.09 <0.001e 0.44 0.17 0.03d 0.35 0.75
rs1871042 (C/T) Intron 6 0.33 0.47 0.78 0.45 0.19 0.87 0.78
rs4891 (T/C) Exon 7 0.31 0.91 0.61 0.64 0.51 0.97 0.17
MAF, minor allele frequency. 
aWe obtained p-values from the chi-square test. Nonwheezing children (n = 485) served as controls for asthma and the wheezing outcomes. bSensitization to inhalant and/or food aller-
gens (IgE ≥ 0.35 kUA/L). We analyzed all available sensitized children, both wheezing cases and controls (nonwheeze, nonsensitized children as controls, n = 362). cp-Values for differ-
ence in PEF mean values for the rare allele versus common allele [linear regression model with model-free coding of genotypes (indicator variables)]. We included all genotyped
children, both wheezing cases and controls, and we adjusted the analyses for age, sex, and height (860 of the 982 genotyped children had acceptable PEF values). dp-Value > 0.05 after
10,000 permutations. ep-Value 0.005 (asthma) and 0.01 (sensitization) after 10,000 permutations.
Table 2. Interaction between SNPs in each gene and exposure to trafﬁc NOx during the ﬁrst year of life with regard to respiratory outcomes, sensitization, and
mean PEF at 4 years of age in children from a birth cohort in Stockholm.
Nominal p-values for interactiona
Localization and Asthma Transient wheezing Late-onset wheezing Persistent wheezing Sensitizationb PEFc
Gene symbol SNP coding change (n = 136 cases) (n = 155 cases) (n = 131 cases) (n = 211 cases) (n = 266 cases) (n = 860)
ADRB2 rs1042714 (C/G) Exon 1, Glu27Gln  0.56 0.39 0.28 0.58 0.10 0.41
rs1042717 (G/A) Exon 1 0.51 0.73 0.22 0.94 0.20 0.35
rs1042718 (C/A) Exon 1 0.06 0.56 0.39 0.59 0.38 0.22
TNF rs1799964 (T/C) –1031 0.73 0.22 0.21 0.53 0.80 0.50
rs1799724 (C/T) –857 0.74 0.61 0.13 0.54 0.12 0.46
rs1800629 (G/A) –308 0.41 0.47 0.09 0.63 0.57 0.80
rs1800610 (C/T) Intron 1 0.74 0.72 0.14 0.69 0.22 0.43
rs3093664 (A/G) Intron 3 0.8 0.05 0.33 0.15 0.63 0.33
GSTP1 rs762803 (C/A) Intron 4 0.26 0.44 0.79 0.29 < 0.001a 0.29
rs1695 (A/G)
(rs947894)  Exon 5, Ile105Val 0.22 0.32 0.73 0.6 0.001a 0.04a
rs749174 (C/T) Intron 5 0.79 0.37 0.87 0.92 0.01a 0.24
rs1138272 (C/T)
(rs1799811)  Exon 6, Ala114Val 0.93 0.69 0.89 0.44 0.06 0.64
rs1871042 (C/T) Intron 6 0.24 0.46 0.76 0.69 0.004a 0.12
rs4891 (T/C) Exon 7 0.25 0.6 0.65 0.34 0.003a 0.006a
We adjusted all analyses for municipality, socioeconomic status, heredity, mother’s smoking during pregnancy, year the house was built, dampness or mold in the home (at birth), and
sex of the child, except for the PEF analyses, which we adjusted for age, sex, height, and municipality. We coded each SNP model free (indicator variables), except for rs1799811,
rs1799724, rs1800610, and rs3093664 (coded 0, 1 because of few rare homozygous individuals). 
aWe obtained p-values for departure from a multiplicative interaction model by likelihood-ratio tests between the models with and without interaction terms. Corrected p-value cutoffs
after correction for multiple tests: 0.01 (corrected for tests on 14 SNPs and sensitization as outcome), < 0.006 (corrected for tests on 14 SNPs and PEF as outcome), 0.01 (corrected for
sensitization and PEF), and < 0.0001 (corrected for all outcomes in the table). bSensitization to inhalant and/or food allergens (IgE ≥ 0.35 kUA/L) in all children, both wheezing cases and
controls (nonwheeze, nonsensitized children as controls, n = 362). cWe included all genotyped children, both wheezing cases and controls, in the PEF analyses (860 of the 982 genotyped
children had acceptable PEF values).the child. We also tested ethnicity in the
model, but it had no confounding effect, so we
did not include it in the ﬁnal model. We per-
formed a permutation test to correct for multi-
ple testing of allelic and haplotype associations
using Haploview (Barrett et al. 2005). We
treated the genotypes and haplotypes as ﬁxed,
whereas we randomized the phenotypes (case
or control). The proportion of 10,000 such
iterations (randomized chi-square tests) that
showed a stronger association than in the
actual data provided the empirical p-value after
correction for multiple tests. For correction of
multiple interaction tests, we used the false dis-
covery rate method developed by Benjamini
and Hochberg (1996) to assess a p-value cutoff
that corresponds to a nominal value of < 0.05
after correction for multiple tests.
Results
We performed screening for overall main
genetic effect using allelic association tests
(Table 1). We observed signiﬁcant associations
between GSTP1 Ala114Val and asthma [Val
vs. Ala: OR = 2.1; 95% confidence interval
(CI), 1.4–3.3] and between TNF-308 and
sensitization to inhalant and/or food allergens
(OR = 1.6; 95% CI, 1.1–2.2, A vs. G), with
p-values < 0.05 after correction for multiple
tests. The GSTP1 114Val allele also had a sug-
gestive association with increased risk of per-
sistent wheezing, and TNF-308A with asthma
and persistent wheezing (p < 0.05 unadjusted).
We saw no clear main genetic effects for
ADRB2. Estimation of the correlation and LD
between the SNPs indicated relatively high
correlation in the GSTP1 gene but generally
low correlation in the TNF gene [Figure 2A–C;
see also Supplemental Material, Figure 1A–C
(http://www.ehponline.org/members/2008/
11117/suppl.pdf)]. Based on the LD pattern,
we deﬁned one haplotype block in each gene
[see Supplemental Material, Figure 1A–C
(http://www.ehponline.org/members/2008/
11117/suppl.pdf)]. We also saw the associa-
tion between TNF and sensitization in haplo-
type analyses of the four SNPs in the block
(e.g., TCAC, p < 0.005), whereas haplotype
associations in the ADRB2 and GSTP1 genes
were not signiﬁcant after correction for multi-
ple tests (data not shown).
We next assessed gene–environment inter-
action effects using exposure to traffic NOx
during the ﬁrst year of life as the environmen-
tal exposure [for main effects of traffic NOx
exposure on all outcomes, see Supplemental
Material, Table 2 (http://www.ehponline.org/
members/2008/11117/suppl.pdf)].
Interaction effects were suggestive between all
tested SNPs in the GSTP1 gene (including the
coding Ile105Val and Ala114Val SNPs,
pnominal < 0.001–0.06) and exposure to trafﬁc
NOx during the ﬁrst year of life for sensitiza-
tion at 4 years of age (Table 2). Correction for
multiple tests did not change the interpreta-
tion of the results. Table 3 lists detailed results
and effect estimates for Ile105Val and
Ala114Val (coding SNPs) interactions.
Children with a 105Val allele (Ile105Val or
Val105Val genotype) had almost a 2.5-fold
increased risk of sensitization (≥ 0.35 kUA/L)
when exposed to elevated levels of trafﬁc NOx
during the first year of life (for a difference
between the 5th and the 95th percentile of
NOx exposure, which corresponds to
44.1 µg/m3 difference; OR = 2.4; 95% CI,
1.0–5.3), whereas we observed no increased
risk in children homozygous for Ile/Ile. For
comparison, Table 3 also presents the overall
main effects (i.e., disregarding possible inter-
action) for these GSTP1 genotypes and for
exposure to trafﬁc NOx during the ﬁrst year of
life, respectively. Using a higher IgE cutoff
level for sensitization (≥ 3.5 kUA/L), we found
a similar association to traffic NOx in the
Ile105Val/Val105Val group (OR = 2.5; 95%
CI, 0.9–6.8). Interaction with respect to PEF
values was also suggestive for two GSTP1
SNPs, including Ile105Val (Table 2).
Children carrying the Ile105Val or Val105Val
genotype had the largest decrease in their PEF
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Table 3. Overall main effects of GSTP1 (Ile105Val and Ala114Val) genotypes and NOx exposure: effect mod-
iﬁcation of NOx exposure, by GSTP1 genotypes, on sensitization at 4 years of age in children from a birth
cohort in Stockholm.
Sensitizationa
Effect Cases/Controls (no.) ORb (95% CI)
Main effects of GSTP1 and NOx
rs947894, Ile105Val
Ile/Ile 113/161 1.0 (referent)
Ile/Val, Val/Val 149/195 1.0 (0.7–1.4)
rs1799811, Ala114Val
Ala/Ala 211/296 1.0 (referent)
Ala/Val, Val/Val 41/47 1.1 (0.7–1.9)
NOx effect 266/362 1.4 (0.7–2.8)
Effect of NOx exposure by GSTP1 genotype, effect modiﬁcation
By rs947894, Ile105Val
Ile/Ile 113/161 0.5  (0.2–1.5)
Ile/Val, Val/Val 149/195 2.4 (1.0–5.3)
By rs1799811, Ala114Val
Ala/Ala 211/296 1.2 (0.5–2.9)
Ala/Val, Val/Val 41/47 4.2 (1.0–18.7)
aSensitization to inhalant and/or food allergens in both wheezing cases and controls at 4 years of age using a cutoff level
of IgE ≥ 0.35 kUA/L. bWe calculated ORs for trafﬁc NOx exposure during the ﬁrst year of life for the difference between the
5th and 95th percentile range of exposure in the cohort, which corresponds to 44 µg/m3 (mean for controls, 22.3 µg/m3).
We calculated OR for GSTP1 genotypes using standard procedures. We adjusted all analyses for municipality, socioeco-
nomic status, heredity, mother’s smoking during pregnancy, year the house was built, dampness or mold in the home (at
birth), and sex of the child. For main effects of GSTP1 genotypes and traffic NOx exposure, we used a model without
gene–environment interaction.
Table 4. Effect modiﬁcation of trafﬁc NOx effects on different outcomes at 4 years of age by GSTP1 Ile105Val and TNF G-308A genotypes.
Sensitizationa Asthma Persistent  wheezing PEFb
GSTP1 Ile105Val TNF –308 Ca/Co (no.) ORc (95% CI) Ca/Co (no.) ORc (95% CI) Ca/Co (no.) ORc (95% CI) (no.) Difference (L/min)
Ile/Ile GG 72/115 0.6 (0.2–2.0) 31/144 0.9 (0.1–5.8) 52/144 3.3 (0.8–13.2) 245 1.6 (–9.3, 12.5)
Ile/Val, Val/Val GG 87/142 1.7 (0.7–4.1) 47/179 2.9 (1.0–8.2) 69/173 3.2 (1.3–7.7) 314 –2.4 (–10.9, 6.1)
p-Value interactiond 0.08 0.16 0.95 0.45
Ile/Ile GA/AA 33/37 0.5 (0.1–4.0) 21/59 0.8 (0.1–5.8) 29/54 0.8 (0.1–1.6) 102 –7.4 (–27.8, 13.1)
Ile/Val, Val/Val GA/AA 52/42 22.0 (1.6–298) 26/69 3.2 (0.5–21.7) 39/68 2.3 (0.4–12.9) 125 –27.8 (–46.8, –8.9)
p-Value interactiond <0.001 0.15 0.20 0.05
p-Value overall interaction  0.001 0.40 0.65 0.32
(three-way)e
Abbreviations: Ca, cases; Co, controls.
aSensitization to inhalant and/or food allergens, IgE ≥ 0.35 kUA/L in both wheezing cases and controls (nonwheeze, nonsensitized children). bWe included all genotyped children (both
wheezing cases and controls) in the PEF analyses. cWe calculated ORs (and PEF difference) for trafﬁc NOx exposure during the ﬁrst year of life for the difference between the 5th and
95th percentile range of exposure in the cohort, which corresponds to 44 µg/m3 (mean for nonwheezing controls, 22.3 µg/m3). We adjusted all analyses for municipality, socioeconomic
status, heredity, mother’s smoking during pregnancy, year the house was built, dampness or mold in the home (at birth), and sex of the child, except for the PEF analyses, which we
adjusted for age, sex, height, and municipality. dp-Value for interaction between GSTP1 genotypes and NOx in each subgroup of TNF-308 GG and GA/AA individuals, respectively.
ep-Value for overall interaction between GSTP1 genotypes, NOx, and TNF genotypes (three-way).values associated with the difference between
the 5th and 95th percentile of exposure to
trafﬁc NOx (on average, –7.2 L/min; 95% CI,
–15.0, 0.5; compared with Ile/Ile subjects,
–1.7 L/min; 95% CI, –11.0, 7.7). However,
the interaction p-value for PEF analyses was
not significant after correction for multiple
tests. The other coding GSTP1 SNP,
Ala114Val, showed an interaction pattern
similar to that for Ile105Val for sensitization
(Table 3), and we saw similar results for the
other GSTP1 SNPs, with heterozygous/rare
homozygous genotype carriers showing
increased risk for sensitization but the com-
mon homozygous individuals showing no sig-
niﬁcant risk (data not shown). In general, the
increased risk seemed to be largely driven by
the heterozygote individuals (e.g., for sensitiza-
tion in Ile105Val heterozygotes, OR = 3.9;
95% CI, 1.4–10.8). However, the number of
individuals in such subgroup analyses is very
small (especially for the rare homozygote
genotype), and this aspect of our results
should be interpreted with caution.
We observed no significant interactions
between variants in the TNF and ADRB2
genes and exposure to trafﬁc NOx with regard
to respiratory symptoms, PEF, or sensitization.
However, TNF and GSTP1 SNPs have been
suggested to have joint effects with respect to
air pollution exposures (Li et al. 2006), and we
assessed whether the gene–environment effect
between NOx exposure and GSTP1 Ile105Val
on sensitization was further modified by the
TNF G-308A SNP. The GSTP1 Ile105Val–air
pollution interaction with respect to sensitiza-
tion was much stronger in children with the
TNF-308 risk genotype (GA/AA) than in
children with the nonrisk genotype (GG)
(p < 0.001 vs. p = 0.08, respectively) (Table 4).
We observed a similar trend to stronger inter-
action in the –308 GA/AA group with respect
to PEF values and, to some extent, persistent
wheeze, although it was not significant.
Notably, children with the GSTP1 Ile105Val/
Val105Val and TNF GA/AA genotypes
exposed to high levels of NOx not only had the
highest risk of sensitization but also showed a
substantial decrease in their PEF values (on
average, –27.8 L/min compared with those
exposed to low levels).
As a sensitivity analysis, we also per-
formed association and interaction tests using
sensitization and PEF as outcomes in the rep-
resentative subcohort of 635 children. The
results and interpretations were very similar to
from analyses including all children (both
wheezing cases and controls), which supports
the general significance of the findings (data
for subcohort only not shown).
Discussion
We present results that support a role of
interactions between a natural antioxidant
enzyme, GSTP1, and long-term exposure to
ambient air pollution from trafﬁc with respect
to sensitization to common allergens in chil-
dren. TNF and ADRB2 polymorphisms did
not seem to directly inﬂuence the effect of air
pollution from trafﬁc on the development of
asthmatic symptoms and sensitization, but in
combination with GSTP1, TNF substantially
modiﬁed the effect of trafﬁc-related exposure.
The GSTP1 enzyme is of particular inter-
est in relation to the respiratory system because
it has been reported to provide more than 90%
of the GST activity in the lung (Fryer et al.
1986). The GSTP1 enzymatic activity has
been shown to differ between isoenzymes with
Ile or Val in amino acid position 105, with
Val105 enzymes having a higher catalytic
capacity for polycyclic aromatic hydrocarbons,
which represent a widespread class of environ-
mental pollutants, but a lower conjugation
capacity for, among others, 1-chloro-2,4-dini-
trobenzene (Sundberg et al. 1998; Watson
et al. 1998). The active GSTP1 enzyme in the
cytosol consists of two subunits that form a
dimer (Reinemer et al. 1991). GSTP1 also
physically interacts with other molecules and
contributes to other biologic pathways, such as
c-Jun N-terminal kinase (JNK), a protein
kinase involved in transcription of cytokines,
immunoglobulins (e.g., IgE), and inﬂamma-
tory enzymes, and 1-cystein peroxiredoxin
(1-Cys Prx), which catalyzes reduction of per-
oxides (Bennett et al. 2001; Ralat et al. 2006).
Dimerization of GSTP1 subunits generates a
catalytically active enzyme, whereas het-
erodimerization of GSTP1 with either JNK or
1-Cys Prx is a mechanism by which the
GSTP1 enzyme exerts additional regulatory
and antioxidative effects.
Conﬂicting results on allergy and asthma
have been presented for individuals homozy-
gous for the Val105 variant. Although some
studies have reported a protective effect for
childhood respiratory illness (Carroll et al.
2005; Fryer et al. 2000; Gilliland et al. 2002c),
others show an association with slower lung
function growth, especially if the child suffers
from asthma (Gilliland et al. 2002a). Further,
two studies were unable to show any effect of
Val105 homozygosity on asthma or atopy
(Brasch-Andersen et al. 2004; Nickel et al.
2005). In the present study, we found no main
effect of Ile105Val polymorphism for the
tested outcomes. Instead, another coding vari-
ant, Ala114Val, was associated with an
increased risk (Val) of asthma at 4 years of age.
However, no association was found between
this polymorphism and asthma in two German
pediatric populations (Nickel et al. 2005). Like
many other studies, we based our asthma diag-
nosis on parentally reported doctor’s diagnosis,
which we did not conﬁrm by a study physician
or any objective measurements, although the
latter is difﬁcult for this age group. The lack of
a detailed, objective asthma definition is, of
course, a limitation in our study and may
explain some discrepancies. Another possible
explanation for the divergent ﬁndings is that
the genetic effect manifests clearly only in
interaction with environmental exposures,
which our results suggest.
Previous interaction studies support the
role of GSTP1 variants modifying the effect of
exposure to air pollutants and tobacco smoke
with respect to asthma and allergy. In an
experimental study, 19 ragweed-sensitized
adults were challenged intranasally with aller-
gen alone and with allergen plus diesel exhaust
particles (Gilliland et al. 2004). Patients
homozygous for the Ile105 variant showed the
largest histamine release and increase in nasal
IgE responses after challenge, and the same
Ile105 homozygote subjects also had the
largest IgE response after challenge with sec-
ond-hand tobacco smoke in a follow-up study
(Gilliland et al. 2006). A study on 61 asth-
matic and 95 nonasthmatic school children
showed that the Ile105Ile genotype conferred
an increased asthma risk only in districts with
high air pollution (deﬁned by high NOx and
Melén et al.
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Figure 2. Block structure and correlation of the SNPs in the ADRB2 gene (A), TNF gene (B), and GSTP1
gene (C). We deﬁned the block structure based on the LD coefﬁcient D´ using Haploview (solid spine of
LD) (Barrett et al. 2005). The numbers in each box correspond to the pairwise correlation coefficient r2
between respective SNPs.
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A B CSO2 levels) (Lee et al. 2004). The Val105
allele frequencies differ somewhat between
these studies, 16% and 22%, respectively,
compared with 33% in our material (no dif-
ference between boys and girls). For HapMap
CEPH samples (from Utah residents with
northern and western Europe ancestry), it is
39% (Altshuler et al. 2005).
High correlation between the GSTP1 SNPs
implies that we cannot directly identify the
SNP responsible for the observed interaction
pattern. Most other studies have focused on the
functional Ile105Val rather than Ala114Val,
because of the low allele frequency and
unknown functional effects of the latter. In the
interactions seen between Ile105Val and trafﬁc
NOx with respect to sensitization, and the
weaker effect but with a similar pattern with
respect to PEF values, carriers of the 105Val
allele (Ile/Val or Val/Val individuals) consis-
tently showed the highest risk estimates in rela-
tion to air pollution levels. These results
contrast with previous studies, where Ile105
homozygotes seem to have the greatest IgE
response after air pollution or tobacco smoke
challenge (Gilliland et al. 2004, 2006). Other
studies have, however, shown that asthmatic
children with two Val105 alleles seem more
likely to experience respiratory symptoms in
response to acute exposure to ozone, rather
than Ile105 homozygotes (Romieu et al. 2006).
A recently published study also showed that
children with GSTP1 Val/Val genotype and a
high activity for EPHX1 (microsomal epoxide
hydrolase, also part of the antioxidative system)
were at the highest asthma risk, especially if
they lived < 75 m from a major road (Salam
et al. 2007).
Whether there are different antioxidant
mechanisms of GSTP1 in response to short- or
long-term exposure to specific air pollutants
remains to be investigated, as well as possible
differences between effects seen in allergic or
asthmatic patients compared with the risk of
developing a disease in previously healthy indi-
viduals. Timing of exposure may also be cru-
cial, and, in contrast to the studies referred to
above, we present data on exposure very early
in life, before onset of any symptom. By using
exposure during the ﬁrst year of life only, we
minimize possible reverse causality induced by
avoidance behavior due to the child’s disease.
At this age, the air pollution levels at the home
address are also highly relevant as exposure esti-
mates, because only 1% of the children in the
study started day care before 12 months of age.
Individual exposure estimates for the different
life years were highly correlated, limiting the
possibility of estimating effects related to spe-
ciﬁc time windows of exposure (Nordling et al.
2008). However, previous results support the
importance of environmental exposure during
the ﬁrst year of life, especially for sensitization
(Lannero et al. 2008).
Although TNF seems to be a key player for
the inﬂammatory response following exposure
to air pollutants, we found no evidence of
effect modiﬁcation by variants in this gene on
the outcomes tested in the initial analyses.
However, in combination with GSTP1, we
found a strong effect modiﬁcation of TNF G-
308A, in that the risk of sensitization and loss
of lung function following NOx exposure was
greatest in children with GSTP1 Ile105Val/
Val105Val and TNF GA/AA genotypes. The
–308A variant has been of particular interest
because of enhanced in vitro transcription and
increased TNF levels in white blood cells
(Wilson et al. 1997). Inconsistent findings
have been reported on the overall inﬂuence of
–308A on susceptibility to asthma and allergy,
although a recent meta-analysis concluded that
the A allele confers a signiﬁcant risk of asthma
(Gao et al. 2006). The same allele was also
associated with sensitization in the main effect
analyses in our study. Importantly, the
G-308A polymorphism has been shown to
modify the effect of both ozone and second-
hand tobacco smoke on respiratory illness,
although the direction of the modiﬁcation dif-
fers between the studies (both G and A alleles
associated with highest risk following exposure)
(Li et al. 2006; Wenten et al. 2005; Wu et al.
2007; Yang et al. 2005). Particularly, the pro-
tective effect of TNF GG genotype (alterna-
tively, the risk effect of TNF GA/AA) seem to
be related to asthma risk predominantly in
subjects from nonsmoking families or children
in low-ozone-exposure communities (Li et al.
2006; Wu et al. 2007). In the study by Li et al.
(2006), the protective effect of TNF GG was
thus reduced in high-ozone communities,
especially in GSTP1 Ile105Ile individuals,
which suggests that the effect of TNF genotype
is dependent on the oxidative defense capacity.
Our findings replicate to some extent the
results of Li et al. (2006) and support the
dependency between GSTP1 and TNF in rela-
tion to air pollution exposures. The TNF risk
genotype (GA/AA) seems to potentiate the risk
associated with exposure, and we speculate that
increased TNF levels may in part explain these
observations, based on previous results on
increased expression associated with the A
allele (Wilson et al. 1997). However, the com-
bined functional effect of GSTP1 and TNF
polymorphisms in relation to air pollution
exposures remains to be elucidated, as well as
the role of GSTP1 in relation to JNK or 1-Cys
Prx as discussed above.
Polymorphisms in the ADRB2 gene (espe-
cially Gly16Arg) have been reported to affect
not only the long-term response to ADRB2
agonists but also the risk of asthma in relation
to active and passive smoking, and we speciﬁ-
cally selected ADRB2 in this study based on
previous interaction effects (Israel et al. 2004;
Wang et al. 2001; Zhang et al. 2007).
Unfortunately, we were unable to study the
effect of Gly16Arg because of genotyping
problems with the technology used, and we
found no interaction for the three remaining
tested polymorphisms, after exclusion for
monomorphic status or deviation from HWE.
However, information from the HapMap pro-
ject shows strong LD between Gly16Arg and
the Gly27Gln variant we studied (D´ = 0.94,
r2 = 0.38) (Altshuler et al. 2005). To our
knowledge, no other study to date has been
published on ADRB2 interactions with air
pollutants other than smoking.
Different gene–environment effects in dif-
ferent settings may occur for several reasons.
The pattern of exposure in observational studies
can differ substantially between countries or
areas, and the genotype frequencies also show
large global differences (Altshuler et al. 2005).
Differences in genotype frequencies have also
been observed in relatively homogenous popu-
lations such as in Sweden (Hannelius et al.
2005). The BAMSE study population was
recruited from the Stockholm area, and only
16% of the children have one or two parents
born outside Scandinavia. We also included
ethnicity in the analyses as a potential con-
founder, but it had no such effect on the inter-
action analyses. This should rule out any major
influence of population stratification.
Insufﬁcient power is also a major concern in
studies on gene–environment interactions,
because the number of individuals with each
combination of a speciﬁc genetic variant and
environmental exposure will be low. A continu-
ous-exposure variable such as NOx in this study
increases the power to detect interactions, but
the number of individuals with different geno-
types who are cases or controls is still limited.
Therefore, we cannot rule out the possibility
that we obtained false-negative results because
of low power. In the whole BAMSE cohort,
NOx exposure was associated with sensitization,
especially to pollen (e.g., for trafﬁc NOx, OR =
1.67; 95% CI, 1.10–2.53) (Nordling et al.
2008). In this subsample of the BAMSE study,
it would have been interesting to look at inter-
action with respect to speciﬁc allergens such as
pollen, but because of insufficient power for
subgroup analyses, we analyzed inhalant and
food allergens jointly. In general, both the main
genetic effects (e.g., TNF-308 SNP) and inter-
action effects (e.g., GSTP1 Ile105Val–NOx)
were somewhat stronger for inhalant allergens
than for food allergens, but the differences were
small, and the directions of association were
similar (data not shown).
There are many practical issues to consider
when attempting examining lung function in
a large group of 4-year-olds. To ensure good-
quality measurements, we used a reproducibil-
ity criterion in addition to the test leader’s
opinion of the child’s effort. The usefulness of
the PEF measurement could be criticized,
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measures used in the diagnostic procedure of
asthma. However, we compared the effect on
airflow between groups of children and did
not attempt to use the PEF measurements as a
tool for diagnosis or diagnostic criterion.
Further, in a previous publication on the same
cohort, we were able to show that PEF is sig-
niﬁcantly reduced in groups of children with
asthma compared with healthy children
(Hallberg et al. 2006).
The possibility of false-positive findings
also needs to be considered, and we have
addressed the multiple testing problems with
false discovery rate analyses, which suggest
that the observed GSTP1–NOx interaction is
likely not to be a false positive. There is, how-
ever, a lack of functional data from experi-
mental studies to directly support our ﬁndings
of gene–environment interactions. Because we
found a high correlation between exposure to
trafﬁc NOx and trafﬁc PM10 in this data set,
we cannot disentangle effects between NOx
and PM10 or, for that matter, other traffic-
related pollutants such as ultrafine particles.
Thus, exposure to source-speciﬁc NOx in this
study should rather be viewed as a proxy for
trafﬁc-related air pollutants.
In conclusion, our data indicate gene–
environment interaction effects on the develop-
ment of allergic diseases in childhood.
Speciﬁcally, variants in the GSTP1 and TNF
genes seemed to modify the effect of early long-
term exposure to ambient air pollution from
trafﬁc with respect to sensitization to common
allergens in children. These results support the
role of genes controlling the antioxidative sys-
tem and inﬂammatory response in the patho-
genesis of allergy and asthma.
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